U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate. At a two-day meeting that starts Monday, a
Geneva, Switzerland and Boston, MA – October 9, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results. Currently, a once-daily
Back pain could be eased by bullet-shaped titanium implant The bullet-shaped implant that could blitz your back pain: Tiny titanium device may offer relief to thousands of sufferers
South San Francisco, CA — July 25, 2018 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive, top line results from